Moneycontrol PRO
HomeNewsBusinessMarketsZydus Lifesciences Appoints Nitin D. Parekh as President (Special Projects)

Zydus Lifesciences Appoints Nitin D. Parekh as President (Special Projects)

Zydus Lifesciences Appoints Nitin D. Parekh as President (Special Projects)

September 05, 2025 / 10:55 IST
Disclaimer This is an AI-assisted live blog with updates sourced from multiple news outlets and agencies Disclaimer
 
 
live
  • bselive
  • nselive
Volume
Todays L/H
More

Zydus Lifesciences has announced the appointment of Nitin D. Parekh as President (Special Projects), effective from September 8, 2025. This decision aims to strengthen the company's management team in response to the increasing scale and complexity of its business operations.

The appointment is based on the recommendation of the Nomination and Remuneration Committee and has been approved by the Board of Directors. Parekh will be part of the Senior Management team.

Nitin D. Parekh, aged 64 years, brings experience with multiple educational qualifications, including CA, CFA, and an MBA from the Indian Institute of Management, Ahmedabad. He is a finance leader with approximately four decades of professional experience across finance, strategy, legal, and IT, spanning both pharma and textiles. His expertise includes M&A, negotiations, capital structure design, and corporate strategy.

Parekh has received national level awards, including Best CFO of Healthcare & Pharma (2025) from Assocham and Hall of Fame (2024) from CFO Collective. He has also been recognized with Excellence in M&A from CII, Best CFO of India-Large Enterprises from Businessworld (2021), and Best CFO of the Healthcare sector in India from ICAI for 2012 and 2017. He has worked for more than 16 years with Zydus Lifesciences Limited as a Chief Financial Officer.

The appointment is made under Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, read with SEBI Circulars dated November 11, 2024, and December 31, 2024.

The term of appointment is 2 years.

Dhaval N. Soni, Company Secretary and Compliance Officer, has disclosed that the disclosure of relationship between directors is not applicable.

The announcement was made on September 5, 2025, with reference number 532321 for BSE Limited and Zyduslife for the National Stock Exchange of India Limited.

Dhaval N. Soni, Company Secretary and Compliance Officer, has disclosed that the disclosure of relationship between directors is not applicable.

Alpha Desk
first published: Sep 5, 2025 10:54 am

Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347